Stereoselective biocatalysis: A mature technology for the asymmetric synthesis of pharmaceutical building blocks*

Biocatalysis and Biotransformation

Volumn 36, Issue 2, 2018, Pages 102-130

  Albarrán Velo, Jesús ^a   González Martínez, Daniel ^a   Gotor Fernández, Vicente ^a  

^a UNIVERSITY OF OVIEDO   (Spain)

Author keywords

Biocascades; biotransformations; hydrolases; natural products; oxidoreductases; pharmaceuticals

Indexed keywords

BIOCATALYSTS; CATALYSIS; DRUG PRODUCTS; HYDROLASES; MOLECULAR BIOLOGY; ORGANOMETALLICS; STEREOCHEMISTRY; STEREOSELECTIVITY;

ASYMMETRIC SYNTHESIS; BIOCASCADES; BIOTRANSFORMATIONS; NATURAL PRODUCTS; OXIDO-REDUCTASES; REACTION CONDITIONS; STEREOSELECTIVE TRANSFORMATIONS; SUBSTRATE SPECIFICITY;

ENZYMES;

ALCOHOL DEHYDROGENASE; HYDROLASE;

ASYMMETRIC SYNTHESIS; BIOCATALYSIS; BIOCATALYST; BIOTRANSFORMATION; CHEMICAL REACTION; CHIRALITY; ENZYME SPECIFICITY; HUMAN; NONHUMAN; REVIEW; STEREOSELECTIVITY;

EID: 85038364121     PISSN: 10242422     EISSN: 10292446     Source Type: Journal    
DOI: 10.1080/10242422.2017.1340457     Document Type: Review

References (83)

1. Agustian J, Kamaruddin AH, Aboul-Enein HY., 2016. Enantio-conversion and -selectivity of racemic Atenolol kinetic resolution using free Pseudomonas fluorescens lipase (Amano) conducted via transesterification reaction. RSC Adv 6:26077–26085.
2. Ahmed ST, Parmeggiani F, Weise NJ, Flitsch SL, Turner NJ., 2015. Chemoenzymatic synthesis of optically pure L- and D-biarylalanines through biocatalytic asymmetric amination and palladium-catalyzed arylation. ACS Catal 5:5410–5413.
3. Ahmed ST, Parmeggiani F, Weise NJ, Flitsch SL, Turner NJ., 2016. Synthesis of enantiomerically pure ring-substituted L-pyridylalanines by biocatalytic hydroamination. Org Lett 18:5468–5471.
4. Batwal RU, Argade NP., 2015. Chemoenzymatic collective synthesis of optically active hydroxyl(methyl)tetrahydronaphthalene-based bioactive terpenoids. Org Biomol Chem 13:11331–11340.
5. Batwal RU, Argade NP., 2016. Chemoenzymatic access to (+)-Artabotriol and its application in collective synthesis of (+)-Grandiamide D, (–)-Tulipalin B, (+)-Spirathundiol, and (+)-Artabotriolcaffeate. Synthesis 48:2130–2136.
6. Belafriekh A, Secundo F, Serra S, Djeghaba Z., 2017. Enantioselective enzymatic resolution of racemic alcohols by lipases in green organic solvents. Tetrahedron Asymmetry 28:473–478.
7. Blasco MA, Gröger H., 2014. Enzymatic resolution of racemates with a ‘remote’ stereogenic center as an efficient tool in drug, flavor and vitamin synthesis. Bioorg Med Chem Lett 22:5539–5546.
8. Blume F, Liu Y-C, Thiel D, Deska J., 2016. Chemoenzymatic total synthesis of (+)- & (−)-cis-osmundalactone. J Mol Catal B: Enzym 134:280–284.
9. Busto E, Simon RC, Richter N, Kroutil W., 2016. One-pot, two-module three-step cascade to transform phenol derivatives to enantiomerically pure (R)- or (S)-p-hydroxyphenyl lactic acids. ACS Catal 6:2393–2397.
10. Chen X, Liu Z-Q, Lin C-P, Zheng Y-G., 2016. Chemoenzymatic synthesis of (S)-duloxetine using carbonyl reductase from Rhodosporidium toruloides. Bioorg Chem 65:82–89.
11. Contente ML, Zambelli P, Galafassi S, Tamborini L, Pinto A, Conti P, et al. 2015. A new chemoenzymatic approach to the synthesis of Latanoprost and Bimatoprost. J Mol Catal B: Enzym 114:7–12.
12. Contente ML, Molinari F, Serra I, Pinto A, Romano D., 2016. Stereoselective enzymatic reduction of ethyl secodione: preparation of a key intermediate for the total synthesis of steroids. Eur J Org Chem 1260–1263.
13. Cunha RLOR, Ferreira EA, Oliveira CS, Omori AT., 2015. Biocatalysis for desymmetrization and resolution of stereocenters beyond the reactive center: how far is far enough? Biotechnol Adv 33:614–623.
14. de Miranda AS, Simon RC, Grischek B, de Paula GC, Horta BAC, de Miranda LSM, et al. 2015. Chiral chlorohydrins from the biocatalyzed reduction of chloroketones: chiral building blocks for antiretroviral drugs. ChemCatChem 7:984–992.
15. de Villiers J, de Villiers M, Geertsema EM, Raj H, Poelarends GJ., 2015. Chemoenzymatic synthesis of ortho-, meta-, and para-substituted derivatives of L-threo-3-benzyloxyaspartate, an important glutamate transporter blocker. ChemCatChem 7:1931–1934.
16. Díaz-Rodríguez A, Ríos-Lombardía N, Sattler JH, Lavandera I, Gotor-Fernández V, Kroutil W, Gotor V., 2015. Deracemisation of profenol core by combining laccase/TEMPO-mediated oxidation and alcohol dehydrogenase-catalysed dynamic kinetic resolution. Catal Sci Technol 5:1443–1446.
17. Drauz K, Gröger H, May O., 2012. Enzyme catalysis in organic synthesis. Weinheim: Wiley-VCH.
18. Dwivedee BP, Ghosh S, Bhaumik J, Banoth L, Banerjee UC., 2015. Lipase-catalyzed green synthesis of enantiopure Atenolol. RSC Adv 5:15850–15860.
19. El-Behairy MF, Sundby E., 2016. One-step lipase-catalysed preparation of Eslicarbazepine. RSC Adv 6:98730–98736.
20. Ferreira IM, Yoshioka SA, Comasseto JV, Porto ALM., 2017. Immobilization of Amano lipase from Pseudomonas fluorescens on silk fibroin spheres: an alternative protocol for the enantioselective synthesis of halohydrins. RSC Adv 7:12650–12658.
21. Fischereder E-M, Pressnitz D, Kroutil W., 2016. Stereoselective cascade to C3-methylated strictosidine derivatives employing transaminases and strictosidine synthases. ACS Catal 6:23–30.
22. Forro E, Galla Z, Fulop F., 2016. The N-hydroxymethyl group as a traceless activating group for the CAL-B-catalysed ring cleavage of β-lactams: a type of two-step cascade reaction. Eur J Org Chem 2647–2652.
23. Fonseca TS, da Silva MR, de Oliveira MCF, de Lemos TLG, Marques RA, de Mattos MC., 2015. Chemoenzymatic synthesis of rasagiline mesylate using lipases. Appl Catal A Gen 492:76–82.
24. Fryszkowska A, Peterson J, Davies NL, Dewar C, Evans G, Bycroft M, et al. 2016. Development of a chemoenzymatic process for dehydroepiandrosterone acetate synthesis. Org Process Res Dev 20:1520–1528.
25. Fuchs M, Farnberger JE, Kroutil W., 2015. The industrial age of biocatalytic transamination. Eur J Org Chem 6965–6982.
26. Fujii M, Morimoto Y, Ono M, Akita H., 2016. Preparation of (S)-γ-cyclogeraniol by lipase-catalyzed transesterification and synthesis of (+)-trixagol and (+)-luffarin-P. J Mol Catal B: Enzym 123:160–166.
27. Gaßmeyer SK, Wetzig J, Mìgge C, Assmann M, Enoki J, Hilterhaus L, et al. 2016. Arylmalonate decarboxylase-catalyzed asymmetric synthesis of both enantiomers of optically pure flurbiprofen. ChemCatChem 2016:916–921.
28. Galla Z, Forró E, Fülöp F., 2016. Enhanced enzymatic synthesis of the enantiopure intermediate for the blockbuster drug intermediate abacavir through a two-step enzymatic cascade reaction. Tetrahedron Asymmetry 27:729–731.
29. Galla Z, Beke F, Forró E, Fülöp F., 2016. Enantioselective hydrolysis of 3,4-disubstituted-β-lactams. An efficient enzymatic method for the preparation of a key Taxolside-chain intermediate. J Mol Catal B: Enzym 123:107–112.
30. Gao S, Zhu S, Huang R, Lu Y, Zheng G., 2015. Efficient synthesis of the intermediate of abacavir and carbovir using a novel (+)-γ-lactamase as a catalyst. Bioorg Med Chem Lett 25:3878–3881.
31. García-Urdiales E, Alfonso I, Gotor V., 2011. Update 1 of: enantioselective enzymatic desymmetrizations in organic synthesis. Chem Rev 111:PR110–PR180.
32. Gérard D, Guéroult M, Casas-Godoy L, Condoret J-S, André I, Marty A, Duquesne S., 2017. Efficient resolution of profen ethyl ester racemates by engineered Yarrowia lipolytica Lip2p lipase. Tetrahedron Asymmetry 28:433–441.
33. Ghosh AK, Sarkar A., 2016. Enantioselective syntheses of (–)-alloyohimbane and (–)-yohimbane by an efficient enzymatic desymmetrization process. Eur J Org Chem 6001–6009.
34. Ghosh AK, Nyalapatla PR., 2017. Total syntheses of both enantiomers of Amphirionin 4: a chemoenzymatic based strategy for functionalized tetrahydrofurans. Tetrahedron 73:1820–1830.
35. Gonzalez R, Nicolau F, Peeples TL., 2017. Optimization of the 11α-hydroxylation of steroid DHEA by solvent-adapted Beauveria bassiana. Biocatal Biotransf 35:103–109.
36. Gourinchas G, Busto E, Killinger M, Richter N, Wiltschi B, Kroutil W., 2015. A synthetic biology approach for the transformation of L-α-amino acids to the corresponding enantiopure (R)- or (S)-α-hydroxyacids. Chem Commun 51:2828–2831.
37. Hernandez KE, Renata H, Lewis RD, Kan SBJ, Zhang C, Forte J, et al. 2016. Highly stereoselective biocatalytic synthesis of key cyclopropane intermediate to ticagrelor. ACS Catal 6:7810–7813.
38. Hinze J, Su¨ss P, Strohmaier S, Bornscheuer UT, Wardenga R, von Langermann J., 2016. Recombinant pig liver esterase-catalyzed synthesis of (1S,4R)-4-hydroxy-2-cyclopentenyl acetate combined with subsequent enantioselective crystallization. Org Process Res Dev 20:1258–1264.
39. Holec C, Sandkuhl D, Rother D, Kroutil W, Pietruszka J., 2015. Chemoenzymatic synthesis towards the active agent travoprost. ChemCatChem 7:3125–3130.
40. Hollmann F, Arends IWCE, Holtmann D., 2011. Enzymatic reductions for the chemist. Green Chem 13:2285–2313.
41. Hou A, Deng Z, Ma H, Liu T., 2016. Substrate screening of amino transaminase for the synthesis of a sitagliptin intermediate. Tetrahedron 72:4660–4664.
42. Hou X, Zhang H, Chen B-C, Guo Z, Singh A, Goswami A, et al. 2017. Regioselective epoxide ring opening for the stereospecific scale-up synthesis of BMS-960, a potent and selective isoxazole-containing S1P1 receptor agonist. Org Process Res Dev 21:200–207.
43. Hugentobler KG, Sharif H, Rasparini M, Heath RS, Turner NJ., 2016. Biocatalytic approaches to a key building block for the anti-thrombotic agent ticagrelor. Org Biomol Chem 14:8064–8067.
44. Hugentobler KG, Rasparini M, Thompson LA, Jolley KE, Blacker AJ, Turner NJ., 2017. Comparison of a batch and flow approach for the lipase-catalyzed resolution of a cyclopropanecarboxylate ester, a key building block for the synthesis of ticagrelor. Org Process Res Dev 21:195–199.
45. Johnson A, Saunders MJ, Back TG., 2015. Stereodivergent synthesis of the LFA-1 antagonist BIRT-377 by porcine liver esterase desymmetrization and Curtius rearrangement. Org Biomol Chem 13:1463–1469.
46. Kiebist J, Schmidtke K-U, Zimmermann J, Kellner H, Jehmlich N, Ullrich R, et al. 2017. A peroxygenase from Chaetomium globosum catalyzes the selective oxygenation of testosterone. ChemBioChem 18:563–569.
47. Khong DT, Pamarthy VS, Gallagher T, Judeh ZMA., 2016. Chemoenzymatic synthesis of chiral 1-benzyl-5-(hydroxymethyl)-2-piperidone enabled by lipase AK-mediated desymmetrization of prochiral 1,3-diol and its diacetate. Eur J Org Chem 3084–3089.
48. Kong X-D, Yu H-L, Yang S, Zhou J, Zeng B-B, Xu J-H., 2015. Chemoenzymatic synthesis of (R)- and (S)-propranolol using an engineered epoxide hydrolase with a high turnover number. J Mol Catal B: Enzym 122:275–281.
49. Larik FA, Saeed A, Channar PA, Mehfoo H., 2016. Stereoselective synthetic approaches towards(S)-duloxetine: 2000 to date. Tetrahedron Asymmetry 27:1101–1112.
50. Lee J, Oh Y, Choi YK, Choi E, Kim K, Park J, Kim M-J., 2015. Dynamic kinetic resolution of diarylmethanols with an activated lipoprotein lipase. ACS Catal 5:683–689.
51. Lindhagen M, Klingstedt T, Andersen SM, Mulholland KR, Tinkler L, McPheators G, Chubb R., 2016. Development of a chemoenzymatic route to (R)-allyl-(3-amino-2-(2-methylbenzyl)propyl)carbamate. Org Process Res Dev 20:65–69.
52. Lo´pez-Iglesias M, Busto E, Gotor V, Gotor FV., 2015. Chemoenzymatic asymmetric synthesis of 1,4-benzoxazine derivatives: application in the synthesis of a levofloxacin precursor. J Org Chem 80:3815–3824.
53. Lund IT, Bøckmann PL, Jacobsen EE., 2016. Highly enantioselective CALB-catalyzed kinetic resolution of building blocks for β-blocker Atenolol. Tetrahedron 72:7288–7292.
54. Mangas-Sánchez J, Busto E, Gotor-Fernández V, Malpartida F, Gotor V., 2012. Asymmetric chemoenzymatic synthesis of miconazole and econazole enantiomers. The importance of chirality in their biological evaluation. J Org Chem 76:2115–2122.
55. Matzel P, Gand M, Höhne M., 2017. One-step asymmetric synthesis of (R)- and (S)-rasagiline by reductive amination applying imine reductases. Green Chem 19:385–389.
56. Méndez-Sánchez D, Mangas-Sánchez J, Lavandera I, Gotor V, Gotor-Fernández V., 2015. Chemoenzymatic deracemization of secondary alcohols by using a TEMPO–iodine–alcohol dehydrogenase system. ChemCatChem 7:4016–4020.
57. Méndez-Sánchez D, López-Iglesias M, Gotor-Fernández V., 2016. Hydrolases in organic chemistry. Recent achievements in the synthesis of pharmaceuticals. Curr Org Chem 20:1186–1203.
58. Moni L, Banfi L, Basso A, Carcone L, Rasparini M, Riva R., 2015. Ugi and Passerini reactions of biocatalytically derived chiral aldehydes: application to the synthesis of bicyclic pyrrolidines and of antiviral agent telaprevir. J Org Chem 80:3411–3428.
59. Mourelle-Insua Á, Lo´pez-Iglesias M, Gotor V, Gotor-Ferna´ndez V, 2016. Stereoselective access to 1-[2-bromo(het)aryloxy]propan-2-amines using transaminases and lipases; development of a chemoenzymatic strategy toward a levofloxacin precursor. J Org Chem 81:9765–9774.
60. Ni Y, Holtmann D, Hollmann F., 2014. How green is biocatalysis? To calculate is to know. ChemCatChem 6:930–943.
61. Nojiri M, Yoshida F, Hirai Y, Nishiyama A, Yasohara Y., 2015. A practical chemoenzymatic synthesis of (R)-isovaline based on the asymmetric hydrolysis of 2-ethyl-2-methyl-malonamide. Tetrahedron Asymmetry 26:1–5.
62. Pedragosa-Moreau S, Flohic AL, Thienpondt V, Lefoulon F, Petit A-M, Ríos-Lombardía N, et al. 2017. Exploiting the biocatalytic toolbox for the asymmetric synthesis of the heart-rate reducing agent ivabradine. Adv Synth Catal 359:485–493.
63. Ramesh P, Harini T, Fadnavis NW., 2015. Efficient resolution of cis-(±)-dimethyl 1-acetylpiperidine-2,3-dicarboxylate with soluble Candida antarctica lipase B (CAL B). Org Process Res Dev 19:296–301.
64. Ren Z-Q, Liu Y, Pei X-Q, Wang H-B, Wu Z-L., 2015. Bioreductive production of enantiopure (S)-duloxetine intermediates catalyzed with ketoreductase ChKRED15. J Mol Catal B: Enzym 113:76–81.
65. Rimoldi I, Facchetti G, Nava D, Contente ML, Gandolfi R., 2016. Efficient methodology to produce a duloxetine precursor using whole cells of Rhodotorula rubra. Tetrahedron Asymmetry 27:389–396.
66. Ryan J, Šiaučiulis M, Gomm A, Maciá B, O’Reilly E, Caprio V, 2016. Transaminase Triggered aza-Michael approach for the enantioselective synthesis of piperidine scaffolds. J Am Chem Soc 138:15798–15800.
67. Schülé A, Merschaert A, Szczepaniak C, Maréchal C, Carly N, O’Rourke J, Ates C., 2016. A biocatalytic route to the novel antiepileptic drug brivaracetam. Org Process Res Dev 20:1566–1577.
68. Shang Y-P, Chen Q, Kong X-D, Zhang Y-J, Xu J-H, Yu H-L., 2017. Efficient synthesis of (R)-2-chloro-1-(2,4-dichlorophenyl)ethanol with a ketoreductase from Scheffersomyces stipitis CBS 6045. Adv Synth Catal 359:426–431.
69. Shao M, Zhang X, Rao Z, Xu M, Yang T, Li H, et al. 2016. Efficient testosterone production by engineered Pichia pastoris co-expressing human 17β-hydroxysteroid dehydrogenase type 3 and Saccharomyces cerevisiae glucose 6-phosphate dehydrogenase with NADPH regeneration. Green Chem 18:1774–1784.
70. Sikora A, Chełminiak-Dudkiewicz D, Siódmiak T, Tarczykowska A, Sroka WD, Ziegler-Borowska M, Marszałł MP., 2016. Enantioselective acetylation of (R,S)-Atenolol: the use of Candida rugosa lipases immobilized onto magnetic chitosan nanoparticles in enzyme-catalyzed biotransformation. J Mol Catal B: Enzym 134:43–50.
71. Sousa CAD, Sampaio-Dias IE, Rizzo-Aguiar F, Garcia-Mera X, Rodríguez-Borges JE., 2015. Enantiopure synthesis of 7-(1-pyrindanyl)propargyl ethers as rasagiline analogues via chemical or enzymatic resolution of 1-pyrindan-7-ol. RSC Adv 5:104509–104515.
72. Srivastava G, Pal M, Kaur S, Jolly RS., 2015. A highly efficient designer cell for enantioselective reduction of ketones. Cat Sci Technol 5:105–108.
73. Sundell R, Kanerva LT., 2015. Studies on N-activation for the lipase-catalyzed enantioselective preparation of β-amino esters from 4-phenylazetidin-2-one. Eur J Org Chem 1500–1506.
74. Tartaggia S, Fogal S, Motterle R, Ferrari C, Pontini M, Aureli R, De Lucchi O., 2016. Chemoenzymatic synthesis of δ-keto-β-hydroxy esters as useful intermediates for preparing statins. Eur J Org Chem 3162–3165.
75. Tyagi V, Alwaseem H, O’Dwyer KM, Ponder J, Li QY, Jordan CT, Fasan R., 2016. Chemoenzymatic synthesis and antileukemic activity of novel C9- and C14-functionalized parthenolide analogs. Bioorg Med Chem 24:3876–3886.
76. Wan N-W, Liu Z-Q, Xue F, Shen Z-Y, Zheng Y-G., 2015. A one-step biocatalytic process for (S)-4-chloro-3-hydroxybutyronitrile using halohydrin dehalogenase: a chiral building block for atorvastatin. ChemCatChem 7:2446–2450.
77. Weiß MS, Pavlidis IV, Spurr P, Hanlon SP, Wirz B, Iding H, Bornscheuer UT., 2016. Protein-engineering of an amine transaminase for the stereoselective synthesis of a pharmaceutically relevant bicyclic amine. Org Biomol Chem 14:10249–10254.
78. Xu G-C, Tang M-H, Ni Y., 2016. Asymmetric synthesis of lipitor chiral intermediate using a robust carbonyl reductase at high substrate to catalyst ratio. J Mol Catal B: Enzym 123:67–72.
79. Xue F, Liu Z-Q, Wan N-W, Zhu H-Q, Zheng Y-G., 2015. Engineering the epoxide hydrolase from Agromyces mediolanus for enhanced enantioselectivity and activity in the kinetic resolution of racemic epichlorohydrin. RSC Adv 5:31525–31532.
80. Yildirim K, Kuru A., 2017. Microbial hydroxylation of epiandrosterone by Aspergillus candidus. Biocatal Biotransf 35:120–126.
81. Yin J-G, Gong Y, Zhang X-Y, Zheng G-W, Xu J-H., 2016. Green access to chiral Vince lactam in a buffer-free aqueous system using a newly identified substrate-tolerant (–)-γ-lactamase. Catal Sci Technol 2:6305–6310.
82. Zhang Y, Wang H, Chen L, Wu K, Xie J, Wei D., 2016. Efficient production of ethyl (R)-4-chloro-3-hydroxybutanoate by a novel alcohol dehydrogenase from Lactobacillus curieae S1L19. J Mol Catal B: Enzym 134A:51–60.
83. Zhao R, Zhang X, Zheng L, Xu H, Li M., 2017. Enantioselective esterification of (R,S)-flurbiprofen catalyzed by lipase in ionic liquid. Green Chem Lett Rev 10:23–28.